Merck & Co.
Search results
Apr 2, 2024 · Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.
- About Us
Roivant builds nimble subsidiaries or “Vants” to develop and...
- Pipeline
Our pipeline includes innovative product candidates across...
- Our Companies
New York. 151 W 42nd Street 15th Floor New York, NY 10036...
- For Investors
Roivant develops transformative medicines faster by building...
- Events & Presentations
Roivant 4Q and Fiscal Year 2022 Earnings Call Presentation...
- Annual Reports
The Investor Relations website contains information about...
- Corporate Governance
Roivant’s Board of Directors sets the highest standards for...
- About Us
Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy .
Roivant develops and commercializes medicines and technologies by creating focused companies called Vants. Learn about their pipeline, launch, culture, and vision.
Roivant Sciences is a public company that builds Vants - biotech and healthcare technology subsidiaries - to deliver innovative medicines and technologies to patients. See their website, locations, employees, updates, and events on LinkedIn.
Roivant is a biopharmaceutical company with a broad and differentiated pipeline of product candidates across immunology, oncology, hematology, and dermatology. It has run 10 positive Phase 3 trials since 2019 and has a nimble, entrepreneurial model of Vants.
Jun 28, 2022 · Roivant Sciences, a biopharmaceutical company with multiple pipeline programs, announced its financial results for the fourth quarter and fiscal year ended March 31, 2022 and provided an update on its operations. Highlights include FDA approval of VTAMA for plaque psoriasis, launch of Priovant with Pfizer, and cash runway of over two years.
Roivant is a biopharmaceutical company that develops and launches Vants, or nimble and focused biotech companies. Find stock information, press releases, and business updates on its investor relations website.
